IQVIA clinical research

Find and learn about IQVIA clinical trials and patient communities. Plus, sign up for alerts for new clinical trials and community updates.

Let’s work together to find a way to prevent COVID-19

Study participants will receive coronavirus 2019 (COVID-19) study-related care at no cost.

Clinical research studies to learn about potential new vaccines, including boosters and vaccines against variants of the virus, are enrolling.

See if you qualify for a vaccine research study

Help us find a way to speed up recovery from COVID-19 and reduce the need for hospital care.


See if you qualify for a treatment research study

Explore posts from across ClinicalResearch.com.
Filter by your area of interest.

For Potential Participants

Children Diagnosed with Type 2 Diabetes at Risk for Serious Complications in Their 20s

Youth with type 2 diabetes at increased risk for high blood pressure, high cholesterol, kidney disease and eye disease in young adulthood, researchers say.

For Potential Participants

HealthDay Now: Alzheimer’s Drug Approval Harms FDA’s Reputation

In a HealthDay Now interview, we spoke with Dr. G. Caleb Alexander, a professor at Johns Hopkins. He served on the FDA advisory committee that nearly unanimously advised against approving Biogen's controversial new Alzheimer's drug. Dr. Alexander discusses whether the FDA's reputation will take a permanent hit due to the drug's approval despite limited evidence of benefit.

Find trials near you

Want more information about clinical trials near you?

Register to get notifications about clinical trials in your area.
Register to Receive Updates